Pharmaceutical Companies Lose $637 Billion in Revenue Annually Due to Medication Nonadherence

HealthPrize Technologies today announced the publication of an update to a research paper co-authored with Capgemini estimating annual pharmaceutical revenue losses of $637 billion due to nonadherence to medications for the treatment of chronic conditions.